Welcome to the Bosentan Patient Registry (BPR) Website

The Bosentan Patient Registry (BPR) is a new initiative established in association with the Pharmaceutical Benefits Scheme (PBS).

The BPR is a database that will collect and store information about the health of people who take bosentan, over a period of three years.

This information is intended to help gain a better understanding of the health outcomes of people who take bosentan for the treatment of PAH. Your doctor will discuss this with you.

This unique Australian drug registry was established in cooperation between Actelion Pharmaceuticals Australia, Monash University CCRE in Therapeutics and the Pharmaceutical Benefits Advisory Committee (PBAC).

Use the navigation menu to the left to view through areas of interest.